SEARCH

SEARCH BY CITATION

References

  • 1
    Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713723.
  • 2
    Racusen LC, Colvin RB, Solex K et al. Antibody-meidated rejection criteria—an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708714.
  • 3
    Olson JL. Hypertension: Essential and secondary forms. In: JennetteJC, OlsonJL, SchwartzMM, SilvaFG, eds. Heptinstall's Pathology of the Kidney, 5th Ed. Philadelphia : Lippincott-Raven, 1998; 9431002.
  • 4
    Morozumi K, Taheda A, Uchida K, Mihatsch MJ. Cyclosporine nephrotoxicity: How does it affect renal allograft function and transplant morphology? Transplant Proc 2004; 36 (Suppl 2S): 251S256S.
  • 5
    Busauschina A, Schnuelle P, Van Der Woude FJ. Cyclosporine nephrotoxicity. Transplant Proc 2004; 36 (Suppl 2S): 229S233S.
  • 6
    Mihatsch MJ, Ryffel B, Gudat F. The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int 1995; 48 (Suppl 52): S63S69.
  • 7
    Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris AJ. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol 1993; 17: 6068.
  • 8
    Mihatsch MJ, Thiel G, Ryffel B. Morphology of ciclosporin nephropathy. Prog Allergy 1986; 38: 447465.
  • 9
    Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl 2003;87:S105S112.
  • 10
    Drachenberg CB, Hirsch HH, Papadimitriou JC. Polyoma virus disease in renal transplantation: Review of pathological findings and diagnostic methods. Hum Pathol 2005; 36: 12451255.
  • 11
    Davenport A, Younie ME, Parsons JE, Kloudia PT. Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection. Nephrol Dial Transplant 1994; 9: 13151319.
  • 12
    Piazza A, Poggi E, Borrelli L et al. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: Posttransplant analysis using flow cytometric techniques. Transplantation 2001; 71: 11061112.
  • 13
    Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RW. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003; 75: 10341040.
  • 14
    Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: A prospective trial. Am J Transplant 2004; 4: 438443.
  • 15
    Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574582.
  • 16
    Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 23712380.
  • 17
    Mroz A, Durlik M, Cieciura T, Lao M. Complement split product C4 as the indicator of immunological activity in chronic allograft rejection. Pol Merkuriusz Lek 2003; 15: 363365.
  • 18
    Vongwiwatana A, Gourishankar S, Campbell PM, Solez K, Halloran PF. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004; 4: 124129.
  • 19
    Sijpkens YW, Joosten SA, Wong M et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004; 65: 24092418.
  • 20
    Herman J, Lerut E, Van Damme-Lombaerts R, Emonds MP, Van Damme B. Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies. Transplantation 2005; 79: 14351440.
  • 21
    Smavatkul C, Baba F, Oberley T, Becker Y, Becker B, Samaniego M. C4d+ chronic allograft nephropathy (CAN): Clinicopathological characteristics and transplant outcomes. Am J Transplant Congress 2004.
  • 22
    Takemoto SK, Zeevi A, Feng S et al. National Conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2003; 4: 10331041.
  • 23
    Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807817.
  • 24
    Poduval RD, Kadambi PV, Josephson MA et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation 2005; 79: 228235.
  • 25
    Reiter Y, Ciobotariu A, Jones J, Morgan BP, Fishelson Z. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis. J Immunol 1995; 155: 22032210.
  • 26
    Sis B, Kaplan B, Halloran PF. Histologic findings from positive crossmatch or ABO-incompatible renal allografts: Accomodation or chronic allograft injury? Am J Transplant 2006; 6: 17531754.
  • 27
    Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: New concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 2002; 11: 609618.
  • 28
    Monga G, Mazzucco G, Novara R, Reale L. Intertubular capillary changes in kidney allografts: An ultrastructural study in patients with transplant glomerulopathy. Ultrastruct Pathol 1990; 14: 201209.
  • 29
    Monga G, Mazzucco G, Messina M, Motta M, Wuaranta S, Novara R. Intertubular capillary changes in kidney allografts: A morphologic investigation on 61 renal specimens. Mod Pathol 1992; 5: 125130.
  • 30
    Ivanyi B, Fahmy H, Brown H, Szenohradszky P, Halloran PF, Solez K. Peritubular capillaries in chronic renal allograft rejection: A quantitative ultrastructural study. Hum Pathol 2000; 31: 11291138.
  • 31
    Gough J, Yilmaz A, Miskulin D et al. Peritubular capillary basement membrane reduplication in allografts and native kidney disease: A clinicopathologic study of 278 consecutive renal specimens. Transplantation 2001; 71: 13901393.
  • 32
    Ivanyi B, Kemeny E, Szederkenyi E, Marofka F, Szenohradszky P. The value of electron microscopy in the daignosis of chronic renal allograft rejection. Mod Pathol 2001; 14: 12001208.
  • 33
    Mauiyyedi S, Nelson C, Tolkoff-Rubin N, Cosimi AB, Schneeberger EE, Colvin RB. Peritubular capillary lamination. A marker of antibody mediated chronic rejection of renal allografts. Mod Pathol 2000;13: 176A.
  • 34
    Drachenberg CB, Steinberger E, Hoehn-Saric E et al. Specificity of intertubular capillary changes: Comparative ultrastructural studies in renal allografts and native kidneys. Ultrastruct Pathol 1997; 21: 227233.
  • 35
    Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242251.
  • 36
    Akalin E, Dikman S, Murphy B, Bromberg JS, Hancock WW. Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy with transplant glomerulopathy. Am J Transplant 2003; 3: 11161120.
  • 37
    Aly ZA, Yalamanchili P, Cortese C, Salinas-Madrigal L, Bastani B. C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: An uncommon finding. Transpl Int 2005; 18: 800805.
  • 38
    Rotman S, Collins AB, Colvin RB. C4d deposition in allografts: Current concepts and interpretation. Transpl Rev 2005: 19; 6577.
  • 39
    Nadasdy GM, Bott C, Cowden D, Pelletier R, Ferguson R, Nadasdy T. Comparative study for the detection of peritubular capillary C4d deposition in human renal allografts using different methodologies. Hum Pathol 2005; 36: 11781185.
  • 40
    Haas M, Rahman MH, Racusen LC et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: Correlation with histologic findings. Am J Transplant 2006; 6: 18291840.
  • 41
    Platt JL. C4d and the fate of organ allografts. J Am Soc Nephrol 2002; 13: 24172419.
  • 42
    Gloor JM, Cosio FG, Rea DJ et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006; 6: 18411847.
  • 43
    Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Analysis using the Banff grading schema. Transplantation 1996; 61: 15861592.
  • 44
    Tinckam KJ, Djurdjev O, Magil AB. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005; 68: 18661874.
  • 45
    Aita K, Yamaguchi Y, Shimizu T et al. Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries. Clin Transplant 2004; 18 (Suppl 11): 712.
  • 46
    Aita K, Yamaguchi Y, Horita S et al. Peritubular capillaritis in early renal allograft is associated with the development of chronic rejection and chronic allograft nephropathy. Clin Transplant 2005; 19 (Suppl 14): 2026.
  • 47
    Vongwiwatana A, Tasanarong A, Hidalgo LG, Halloran PF. The role of B cells and alloantibody in the host response to human organ allografts. Immunol Rev 2003; 196: 197218.
  • 48
    Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603612.
  • 49
    Nast CC, Moudgil A, Zuo XJ, Wilkinson A, Danovitch GM, Jordan SC. Cyclosporine microemulsion- and mycophenolate mofetil-related lymphoid aggregates are not associated with acute rejection. Transplantation 2001; 72: 251256.
  • 50
    Cascalho M. B cell tolerance: Lessons from transplantation. Curr Drug Targets Cardiovasc Haematol Sisord 2005; 5: 271275.
  • 51
    Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125138.
  • 52
    Racusen L. Molecular techniques in transplantation. Transplant Proc 2004; 36: 731732.
  • 53
    Satterwhite T, Chua MS, Hsieh SC et al. Increased expression of cytotoxic effector molecules: Different interpretations for steroid-based and steroid-free regimens. Pediatr Transplant 2003; 7: 46.
  • 54
    Flechner SM, Kurian SM, Head SR et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4: 14751489.